BioTech Medics, Inc. (PINKSHEETS: BTMD) announced June 23, 2006, that it has contracted with Retroscreen Virology, at the University of London, Queen Mary's School of Medicine, London to conduct a study to determine the efficacy of viricidal SHBAN against Avian HSN1 Influenza NIBRG-14 Virus (also known as the Avian Bird Flu).
